PetCareRx.com Revenue and Competitors

Lynbrook, NY USA

Location

N/A

Total Funding

Retail

Industry

Estimated Revenue & Valuation

  • PetCareRx.com's estimated annual revenue is currently $13.9M per year.(i)
  • PetCareRx.com's estimated revenue per employee is $167,378

Employee Data

  • PetCareRx.com has 83 Employees.(i)
  • PetCareRx.com grew their employee count by 6% last year.

PetCareRx.com's People

NameTitleEmail/Phone
1
CTOReveal Email/Phone
2
ControllerReveal Email/Phone
3
Distribution Center ManagerReveal Email/Phone
4
Security ManagerReveal Email/Phone
5
Customer Communications ManagerReveal Email/Phone
6
Warehouse Team LeadReveal Email/Phone
7
PetCareRx Pharmacy DirReveal Email/Phone
8
MarketingReveal Email/Phone
9
Assistant ControllerReveal Email/Phone
10
Software Architect, Senior .NET DeveloperReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.7M23N/AN/AN/A
#2
$12.7M62-9%N/AN/A
#3
$13.7M6729%N/AN/A
#4
$4.6M2921%N/AN/A
#5
$0.7M60%N/AN/A
#6
$43.2M1735%N/AN/A
#7
$6.9M389%N/AN/A
#8
$1549M48748%N/AN/A
#9
$6.9M383%N/AN/A
#10
$13.5M6616%N/AN/A
Add Company

What Is PetCareRx.com?

PetCareRx was established to give you the products you need, at the discounts you deserve, by supplying pet medications and all of your pet's other health needs at a fraction of what they cost when dispensed by a veterinarian Arthritis is very common in dogs as they age, and the inflammation in the joints can cause them a lot of pain. Pet meds are available to help ease your dog's pain and discomfort

keywords:N/A

N/A

Total Funding

83

Number of Employees

$13.9M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PetCareRx.com News

2022-04-17 - Is My Dog Depressed? 5 Symptoms to Look Out For

PetCareRx, a pet pharmacy that deals with nearly every canine medication on the planet, states dogs who are feeling low typically eat less...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.3M103-8%N/A
#2
$40.9M1245%N/A
#3
$24.5M13611%N/A
#4
$43.4M1657%N/A
#5
$56M1672%N/A